Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jan 17;15(1):15.
doi: 10.3390/jox15010015.

The Issue of "Smart Drugs" on the Example of Modafinil: Toxicological Analysis of Evidences and Biological Samples

Karolina Nowak  1 , Agnieszka Chłopaś-Konowałek  2 , Paweł Szpot  3 , Marcin Zawadzki  4   5
Affiliations

The Issue of "Smart Drugs" on the Example of Modafinil: Toxicological Analysis of Evidences and Biological Samples

Karolina Nowak et al. J Xenobiot. .

Abstract

Cognitive enhancement through stimulants such as modafinil is becoming increasingly popular, with many individuals using prescription stimulants for non-medical purposes to improve alertness, attention, and mood. The misuse of such substances has raised concerns, particularly in forensic toxicology. The UHPLC-QqQ-MS/MS method was developed to quantify modafinil in evidentiary samples and biological materials. Additionally, the authors noted the presence of sodium adducts during the analysis of samples with high concentrations of modafinil. The method was validated for accuracy, precision, and linearity, with a concentration range of 0.1-10.0 µg/mL for the evidences and 1.0-100.0 ng/mL for blood. The method successfully detected modafinil as the sole substance in all evidences, with concentrations ranging from 90.7 to 120.8 mg, corresponding to 45.5% to 80.5% of the labeled dose. The method was applied to real post-mortem human cases, where, among others, the concentration of modafinil in blood was 110 ng/mL, whereas, in another case, the concentration of modafinil in the putrefaction fluid exceeded 1000 ng/mL. The developed UHPLC-QqQ-MS/MS method is effective for the quantification of modafinil in evidentiary samples and biological materials, offering a reliable tool for forensic toxicology applications. This method can be used to evaluate modafinil use in both legal and illicit contexts, including cases of overdose or misuse.

Keywords: UHPLC-QqQ-MS/MS; biological material; evidence; forensic toxicology; modafinil.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Fragments of blisters with tested samples. View from two sides of blisters.
Figure 1
Figure 1
Fragments of blisters with tested samples. View from two sides of blisters.
Figure 2
Figure 2
Q3 scan of one of analyzed evidences.
Figure 3
Figure 3
Structures of sodium adduct that can be observed in analyzed evidences.
Figure 4
Figure 4
Mass spectra of modafinil in product ion scan mode (CE: 10 (A), 20 (B), and 35 V (C)).
See this image and copyright information in PMC

Similar articles

See all similar articles

References

    1. Repantis D., Schlattmann P., Laisney O., Heuser I. Modafinil and methylphenidate for neuroenhancement in healthy individuals: A systematic review. Pharmacol. Res. 2010;62:187–206. - PubMed
    1. Settineri S., Gitto L., Conte F., Fanara G., Mallamace D., Mento C., Silvestri R., Tati F., Zoccali R., Cordici F., et al. Mood and sleep problems in adolescents and young adults: An econometric analysis. J. Ment. Health Policy Econ. 2012;15:33–41. - PubMed
    1. Dresler M., Sandberg A., Bublitz C., Ohla K., Trenado C., Mroczko-Wasowicz A., Kühn S., Repantis D. Hacking the brain: Dimensions of cognitive enhancement. ACS Chem. Neurosci. 2018;10:1137–1148. doi: 10.1021/acschemneuro.8b00571. - DOI - PMC - PubMed
    1. Farah M.J., Illes J., Cook-Deegan R., Gardner H., Kandel E., King P., Parens E., Sahakian B., Wolpe P.R. Neurocognitive enhancement: What can we do and what should we do? Nat. Rev. Neurosci. 2004;5:421–425. doi: 10.1038/nrn1390. - DOI - PubMed
    1. Smith M.E., Farah M.J. Are prescription stimulants “smart pills”? The epidemiology and cognitive neuroscience of prescription stimulant use by normal healthy individuals. Psychol. Bull. 2011;137:717–741. - PMC - PubMed

LinkOut - more resources